Computational Chemistry and Molecular Modeling of Reversible MAO Inhibitors
dc.authorscopusid | 6506158277 | |
dc.authorscopusid | 24463261600 | |
dc.contributor.author | Yelekçi, Kemal | |
dc.contributor.author | Erdem, S.S. | |
dc.date.accessioned | 2023-10-19T15:05:15Z | |
dc.date.available | 2023-10-19T15:05:15Z | |
dc.date.issued | 2023 | |
dc.department-temp | Yelekçi, K., Department of Bioinformatics and Genetics, Faculty of Engineering and Natural Sciences, Kadir Has University, Istanbul, Turkey; Erdem, S.S., Department of Chemistry, Faculty of Arts and Sciences, Marmara University, Istanbul, Turkey | en_US |
dc.description.abstract | Proper elucidation of drug-target interaction is one of the most significant steps at the early stages of the drug development research. Computer-aided drug design tools have substantial contribution to this stage. In this chapter, we specifically concentrate on the computational methods widely used to develop reversible inhibitors for monoamine oxidase (MAO) isozymes. In this context, current computational techniques in identifying the best drug candidates showing high potency are discussed. The protocols of structure-based drug design methodologies, namely, molecular docking, in silico screening, and molecular dynamics simulations, are presented. Employing case studies of safinamide binding to MAO B, we demonstrate how to use AutoDock 4.2.6 and NAMD software packages. © 2023, The Author(s), under exclusive license to Springer Science+Business Media, LLC, part of Springer Nature. | en_US |
dc.identifier.citation | 4 | |
dc.identifier.doi | 10.1007/978-1-0716-2643-6_17 | en_US |
dc.identifier.endpage | 252 | en_US |
dc.identifier.issn | 1064-3745 | |
dc.identifier.pmid | 36169867 | en_US |
dc.identifier.scopus | 2-s2.0-85139376065 | en_US |
dc.identifier.scopusquality | N/A | |
dc.identifier.startpage | 221 | en_US |
dc.identifier.uri | https://doi.org/10.1007/978-1-0716-2643-6_17 | |
dc.identifier.uri | https://hdl.handle.net/20.500.12469/4776 | |
dc.identifier.volume | 2558 | en_US |
dc.identifier.wosquality | N/A | |
dc.khas | 20231019-Scopus | en_US |
dc.language.iso | en | en_US |
dc.publisher | Humana Press Inc. | en_US |
dc.relation.ispartof | Methods in Molecular Biology | en_US |
dc.relation.publicationcategory | Kitap Bölümü - Uluslararası | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | Docking | en_US |
dc.subject | Molecular dynamics | en_US |
dc.subject | Monoamine oxidase | en_US |
dc.subject | Virtual screening | en_US |
dc.subject | monoamine oxidase inhibitor | en_US |
dc.subject | safinamide | en_US |
dc.subject | selegiline | en_US |
dc.subject | amine oxidase (flavin containing) | en_US |
dc.subject | isoenzyme | en_US |
dc.subject | monoamine oxidase inhibitor | en_US |
dc.subject | cheminformatics | en_US |
dc.subject | controlled study | en_US |
dc.subject | drug protein binding | en_US |
dc.subject | drug screening | en_US |
dc.subject | molecular docking | en_US |
dc.subject | molecular model | en_US |
dc.subject | chemistry | en_US |
dc.subject | metabolism | en_US |
dc.subject | structure activity relation | en_US |
dc.subject | Computational Chemistry | en_US |
dc.subject | Isoenzymes | en_US |
dc.subject | Molecular Docking Simulation | en_US |
dc.subject | Monoamine Oxidase | en_US |
dc.subject | Monoamine Oxidase Inhibitors | en_US |
dc.subject | Structure-Activity Relationship | en_US |
dc.title | Computational Chemistry and Molecular Modeling of Reversible MAO Inhibitors | en_US |
dc.type | Book Part | en_US |
dspace.entity.type | Publication | |
relation.isAuthorOfPublication | 9407938e-3d31-453b-9199-aaa8280a66c5 | |
relation.isAuthorOfPublication.latestForDiscovery | 9407938e-3d31-453b-9199-aaa8280a66c5 |